1. Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. The Lancet. 2012; 379:55-70.
2. United Nations Office on Drugs and Crime. World drug report, 2018. http://www.unodc.org/wdr2018/prelaunch/WDR18_Booklet_2_GLOBAL.pdf. Accessed 15 Jun 2019.
3. Degenhardt L, Copeland J, Dillon P. Recent trends in the use of "club drugs": an Australian review. SUBST USE MISUSE. 2005; 40:1241-1256.
4. Chen X, Li X, Zheng J, Zhao J, He J, Zhang G, et al. Club Drugs and HIV/STD Infection: An Exploratory Analysis among Men Who Have Sex with Men in Changsha, China. PLOS ONE. 2015; 10:e126320.
5. Ding Y, He N, Zhu W, Detels R. Sexual Risk Behaviors among Club Drug Users in Shanghai, China: Prevalence and Correlates. AIDS BEHAV. 2013; 17:2439-2449.
6. WHO. HIV/AIDS [EB/OL].
https://www.who.int/news-room/fact-sheets /detail/hiv-aids. Accessed 30 Jul 2019.
7. Beekmann SE, Henderson DK. Prevention of Human Immunodeficiency Virus and AIDS. INFECT DIS CLIN N AM. 2014; 28:601-613.
8. Beanland RL, Irvine CM, Green K. End Users’ Views and Preferences on Prescribing and Taking Postexposure Prophylaxis for Prevention of HIV: Methods to Support World Health Organization Guideline Development. CLIN INFECT DIS. 2015; 60:S191-S195.
9. Goldschmidt RH. CDC Releases Updated Guidelines for Postexposure Prophylaxis After Sexual, Injection Drug, or Other Nonoccupational Exposures to HIV. AM FAM PHYSICIAN. 2016; 94:392-393.
10. Libois A, Florence E, Derdelinckx I, Yombi J.C, Henrard S, Uurlings F, et al. Belgian guidelines for non-occupational HIV post-exposure prophylaxis 2017. ACTA CLIN BELG. 2018; 73:275-280.
11. Bamford A, Tudor-Williams G, Foster C. Post-exposure prophylaxis guidelines for children and adolescents potentially exposed to HIV. ARCH DIS CHILD. 2016; 102:78-83.
12. Wang L, Guo W, Li D, Ding Z, McGoogan J.M, Wang N, et al. HIV epidemic among drug users in China: 1995-2011. ADDICTION. 2015; 110:20-28.
13. General Office of National Narcotics Control Commission. Annual report in drug control in China, 2018. http://www.nncc626.com/2019-06/17/c_1210161797.htm. Accessed 30 Jul 2019. (In Chinese)
14. Hoenigl M, Chaillon A, Moore DJ, Morris S.R., Smith D.M., Little S.J. Clear Links Between Starting Methamphetamine and Increasing Sexual Risk Behavior: A Cohort Study Among Men Who Have Sex With Men. J Acquir Immune Defic Syndr. 2016; 71:551-557.
15. Melendez-Torres GJ, Bourne A. Illicit drug use and its association with sexual risk behaviour among MSM: more questions than answers? CURR OPIN INFECT DIS. 2016; 29:58-63.
16. National Center for AIDS/STD Control and Prevention, China CDC. Update on the AIDS/STD epidemic in China the third quarter of 2018. Chinese Journal of AIDS & STD. 2018; 24:1075. (In Chinese)
17. National Center for AIDS/STD Control and Prevention, China CDC. Update on the AIDS/STD epidemic in China and main response in control and prevention in the third quarter of 2012. Chinese Journal of AIDS & STD 2012;18:719. (In Chinese)
18. Zeng Z, Liu H, Xu J, Lan G, Wang L, Yin W. Demand for non-occupational post-exposure prophylaxis and its influencing factors among 344 men who have sex with men in Guangxi. Chinese Journal of AIDS & STD. 2017; 23:620-624. (In Chinese)
19. Wang C, Duan Q, Chen Q, Bi Y, Li Y, Kang D. High-risk sexual behavior and preventive effects of men receiving HIV non-occupational post-exposure prophylaxis in Jinan. Chinese Journal of AIDS & STD. 2018; 24:1221-1223. (In Chinese)
20. Jiang Z, Xiu C, Yang J, Zhang X, Liu M, Chen X. HIV test uptake and related factors amongst heterosexual drug users in Shandong province, China. PLOS ONE. 2018;13:e204489.
21. Pope C, Ziebland S, Mays N. Qualitative research in health care. Analysing qualitative data. BMJ. 2000;320:114-116.
22. Lin SY, Lachowsky NJ, Hull M, Rich A, Cui Z, Sereda P, et al. Awareness and use of nonoccupational post-exposure prophylaxis among men who have sex with men in Vancouver, Canada. HIV MED. 2016;17:662-673.
23. Han Q, Han D. A survey of depression status for neotype drug abuseres during compulsory detoxification. JOURNAL OF CLINICAL PSYCHOSOMATIC DISEASES. 2009;15:106-108. (In Chinese)
24. Medley A, Kennedy C, O'Reilly K, Sweat M. Effectiveness of Peer Education Interventions for HIV Prevention in Developing Countries: A Systematic Review and Meta-Analysis. AIDS EDUC PREV. 2009; 21:181-206.
25. Mitchell JW, Sophus AI, Petroll AE. HIV-Negative Partnered Men's Willingness to Use Non-Occupational Post-Exposure Prophylaxis and Associated Factors in a U.S. Sample of HIV-Negative and HIV-Discordant Male Couples. LGBT HEALTH. 2016; 3:146-152.
26. Broadbent J, Dakki MA. How Much Is Too Much to Pay for Internet Access? A Behavioral Economic Analysis of Internet Use. Cyberpsychology, Behavior, and Social Networking. 2015; 18:457-461.
27. Gulholm T, Jamani S, Poynten IM, Templeton DJ. Non-occupational HIV post-exposure prophylaxis at a Sydney metropolitan sexual health clinic. SEX HEALTH. 2013; 10:438-441.
28. Li H, Cheng Y, Yang C. Safety, tolerability and effectiveness of HIV non-occupational prophylaxis in Taiwan. J INT AIDS SOC. 2014; 17:19736.
29. Teo AKJ, Tai BC, Chio MT, La HH. A mixed methods study of non-occupational post-exposure prophylaxis at an STI clinic in Singapore: Five-year retrospective analysis and providers' perspectives. PLOS ONE. 2018; 13:e202267.
30. Palich R, Martin-Blondel G, Cuzin L, Le Talec J, Boyer P, Massip P, et al. Experiences of HIV postexposure prophylaxis (PEP) among highly exposed men who have sex with men (MSM). SEX TRANSM INFECT. 2017; 93:493-498.
31. Tissot F, Erard V, Dang T, Cavassini M. Nonoccupational HIV post-exposure prophylaxis: a 10-year retrospective analysis. HIV MED. 2010; 11:584-592.
32. Smith DK, Grohskopf LA, Black RJ, Auerbach J.D, Veronese F, Struble K.A, et al. Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services. MMWR Recomm Rep. 2005; 54:1-20.
33. Minas B, Laing S, Jordan H, Mak DB. Improved awareness and appropriate use of non-occupational post-exposure prophylaxis (nPEP) for HIV prevention following a multi-modal communication strategy. BMC PUBLIC HEALTH. 2012; 12:906.
34. Malinverni S, Gennotte A, Schuster M, De Wit S, Mols P, Libois A. Adherence to HIV post-exposure prophylaxis: A multivariate regression analysis of a 5 years prospective cohort. J INFECTION. 2018; 76:78-85.
35. Nachega JB, Parienti J, Uthman OA, Gross R, Dowdy D.W, Sax P.E, et al. Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials. CLIN INFECT DIS. 2014; 58:1297-1307.
36. Kahn JO, Martin JN, Roland ME, Bamberger J.D, Chesney M, Chambers D, et al. Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study. J INFECT DIS. 2001; 183:707-714.
37. Wodajo BS, Thupayagale-Tshweneagae G, Akpor OA. HIV and AIDS-related stigma and discrimination in two referral hospitals in Ethiopia. Afr J AIDS Res. 2017; 16:137-144.
38. Kabbash IA, Abo AE, Elgendy MM, Abdrabo M.M, Salem H.M, Gouda M.R, et al. HIV/AIDS-related stigma and discrimination among health care workers at Tanta University Hospitals, Egypt. Environ Sci Pollut Res Int. 2018; 25:30755-30762.
39. Dong X, Yang J, Peng L, Pang M, Zhang J, Zhang Z, et al. HIV-related stigma and discrimination amongst healthcare providers in Guangzhou, China. BMC PUBLIC HEALTH. 2018; 18.
40. Liao M, Kang D, Tao X, Bouey J.H, Aliyu M.H, Qian Y, et al. Alcohol Use, Stigmatizing/Discriminatory Attitudes, and HIV High-Risk Sexual Behaviors among Men Who Have Sex with Men in China. BIOMED RES INT. 2014; 2014:1-8.
41. Li X, Lu H, Ma X, Sun Y, He X, Li C, et al. HIV/AIDS-related stigmatizing and discriminatory attitudes and recent HIV testing among men who have sex with men in Beijing. AIDS BEHAV. 2012; 16:499-507.
42. Epple R, Blanes L, Beavis A, Roux C, Doble P. Analysis of amphetamine-type substances by capillary zone electrophoresis using capacitively coupled contactless conductivity detection. ELECTROPHORESIS. 2010; 31:2608-2613.
43. Cassell MM, Halperin DT, Shelton JD, Stanton D. Risk compensation: the Achilles' heel of innovations in HIV prevention? BMJ. 2006; 332:605-607.
44. Cao B, Gupta S, Wang J, Hightow-Weidman L.B, Muessig K.E, Tang W, et al. Social Media Interventions to Promote HIV Testing, Linkage, Adherence, and Retention: Systematic Review and Meta-Analysis. J MED INTERNET RES. 2017; 19:e394.